Intra-Cellular Therapies, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ALKS
Alkermes plc |
$27.00 | $4.45 B | 12.27 | 1800 |
AMPH
Amphastar Pharmaceuticals, Inc. |
$24.16 | $1.15 B | 7.89 | 2028 |
AMRX
Amneal Pharmaceuticals, Inc. |
$6.98 | $3.25 B | -18.36 | 8300 |
ANIP
ANI Pharmaceuticals, Inc. |
$68.12 | $1.47 B | -65.54 | 897 |
AQST
Aquestive Therapeutics, Inc. |
$2.47 | $243.72 M | -4.83 | 142 |
COLL
Collegium Pharmaceutical, Inc. |
$26.30 | $845.71 M | 15.13 | 357 |
CYTH
Cyclo Therapeutics, Inc. |
$0.72 | $23.59 M | -0.8 | 8 |
DCPH
Deciphera Pharmaceuticals, Inc. |
$25.59 | $2.21 B | -11.58 | 355 |
DVAX
Dynavax Technologies Corporation |
$11.25 | $1.40 B | 56.25 | 405 |
EGRX
Eagle Pharmaceuticals, Inc. |
$1.25 | $19.44 M | 1.76 | 134 |
IRWD
Ironwood Pharmaceuticals, Inc. |
$0.95 | $152.00 M | 93.94 | 253 |
NBIX
Neurocrine Biosciences, Inc. |
$90.87 | $9.06 B | 29.02 | 1800 |
PCRX
Pacira BioSciences, Inc. |
$24.56 | $1.14 B | -11.42 | 788 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
